Sotera Health Company logo SHC - Sotera Health Company

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 11
HOLD 0
SELL 1
STRONG
SELL 0
| PRICE TARGET: $21.33 DETAILS
HIGH: $25.00
LOW: $19.00
MEDIAN: $20.00
CONSENSUS: $21.33
UPSIDE: 20.03%

Stock News

Sotera Health Announces Third-Quarter 2026 Earnings Release Date

Sotera Health Announces Third-Quarter 2026 Earnings Release Date

CLEVELAND, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the third quarter ended September 30, 2026 before the market opens on Tuesday, November 3, 2026. Following the release, management will host a conference call at 9:00 a.m.

Oct 21, 2026 03:00 AM • globenewswire.com
Sotera Health: Pricing Power And Recurring Revenues Are Growth Drivers

Sotera Health: Pricing Power And Recurring Revenues Are Growth Drivers

Sotera Health Company is rated BUY, leveraging a vertically integrated model and strong MOAT in global medical equipment sterilization. SHC benefits from high customer switching costs, multi-year contracts with major healthcare firms, and robust pricing power in mission critical services. Q2 2026 results exceeded expectations, prompting raised full-year guidance; SHC trades at a discount to peers on forward EV/EBITDA despite superior margins.

Sep 18, 2026 10:45 AM • seekingalpha.com
Contrasting Sotera Health (NASDAQ:SHC) & WuXi AppTec (OTCMKTS:WUXIF)

Contrasting Sotera Health (NASDAQ:SHC) & WuXi AppTec (OTCMKTS:WUXIF)

Sotera Health (NASDAQ: SHC - Get Free Report) and WuXi AppTec (OTCMKTS:WUXIF - Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, profitability and earnings. Insider and Institutional Ownership 91.0% of Sotera Health

Aug 20, 2026 10:29 PM • defenseworld.net
Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook

Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook

Q2 2026 net revenues increased 9.2% or 8.0% on a constant currency basis (1) compared to Q2 2025 Q2 2026 net income of $54 million or $0.19 per diluted share, compared to net income of $8 million or $0.03 per diluted share in Q2 2025 Q2 2026 Adjusted EBITDA ( 1 ) increased 10.0%, or 8.7% on a constant currency basis Q2 2026 Adjusted EPS (1) of $0.26, an increase of 30% per diluted share Company raises both full-year 2026 net revenues growth out look to 5.25% - 6.75% and Adjusted EBITDA growth outlook to 5.75% - 7.25%, on a constant currency basis CLEVELAND, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the three- and six- months ended June 30, 2026. “We delivered another strong quarter, with high-single-digit growth, reflecting focused execution across all three of our business units,” said Chief Executive Officer Alton Shader.

Aug 06, 2026 03:00 AM • globenewswire.com
Sotera Health Announces Second-Quarter 2026 Earnings Release Date

Sotera Health Announces Second-Quarter 2026 Earnings Release Date

CLEVELAND, July 23, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the second-quarter ended June 30, 2026 before the market opens on Thursday, August 6, 2026. Following the release, management will host a conference call at 9:00 a.m.

Jul 23, 2026 03:00 AM • globenewswire.com

Price Targets